This inventor holds 9 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Perry Hall, MD (US) (2016)
- Ellicott City, MD (US) (2019 - 2021)
- Baltimore, MD (US) (2015 - 2024)
Company Filing History:
Years Active: 2015-2026
Title: The Innovative Contributions of Srinivasan Yegnasubramanian
Introduction
Srinivasan Yegnasubramanian is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research, holding a total of 9 patents. His work focuses on the development of novel therapeutic strategies that leverage epigenetic mechanisms to combat cancer.
Latest Patents
One of his latest patents is titled "Induction of synthetic lethality with epigenetic therapy." This invention relates to compositions and methods for treating cancer by inducing synthetic lethality through a combination of epigenetic compounds and chemotherapeutic agents. The patent also includes screening methods for identifying compounds that can effectively kill cancer cells when used alongside epigenetic therapies. Another notable patent is "Agents for reversing epigenetic silencing of genes." This invention provides methods for discovering agents that can reverse epigenetic silencing by inhibiting the interaction of methyl-binding proteins with methylated genomic DNA. It also outlines methods for reactivating silenced genes and offers potential treatments for diseases such as cancer and sickle cell anemia.
Career Highlights
Srinivasan Yegnasubramanian is affiliated with The Johns Hopkins University, where he conducts his research and development work. His innovative approaches have positioned him as a key figure in the field of epigenetics and cancer therapy.
Collaborations
He has collaborated with notable colleagues, including William G Nelson and Xiaohui S Lin, to advance research in his area of expertise.
Conclusion
Srinivasan Yegnasubramanian's contributions to cancer research through his innovative patents highlight the potential of epigenetic therapies in treating complex diseases. His work continues to pave the way for new therapeutic strategies that could significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile